Bon Natural Life (BON)
NASDAQ:BON
Top Page
Bon Natural Life
(NASDAQ:BON)
Select Model
Select Model
Rating:46Neutral
Price Target:
$1.50
▼(-11.76% Downside)
Action:DowngradedDate:01/26/26
The score is primarily constrained by weak financial performance—especially persistent negative free cash flow and deteriorating profitability. Technical indicators are mixed/neutral with mild bearish momentum, and valuation is challenging due to losses (negative P/E) with no dividend support.
Positive Factors
Balance-sheet buffer and manageable leverage
A low debt-to-equity (~0.21) and materially higher equity versus prior years provide a durable liquidity cushion and financing optionality. This balance-sheet buffer reduces near-term refinancing urgency and supports investment or working-capital needs while management works to restore profitability.
Negative Factors
Persistent negative free cash flow
Ongoing cash burn and very thin operating cash generation force reliance on external funding or balance-sheet liquidity. Over a multi-month horizon this constrains the company’s ability to fund R&D, scale manufacturing, or absorb shocks without dilutive financing or higher debt.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance-sheet buffer and manageable leverage
A low debt-to-equity (~0.21) and materially higher equity versus prior years provide a durable liquidity cushion and financing optionality. This balance-sheet buffer reduces near-term refinancing urgency and supports investment or working-capital needs while management works to restore profitability.
Read all positive factors
Bon Natural Life (BON) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$10.81M
Dividend YieldN/A
Average Volume (3M)2.24M
Price to Earnings (P/E)―
Beta (1Y)1.81
Revenue Growth-15.44%
EPS Growth-94.04%
CountryUS
Employees97
SectorBasic Materials
Sector Strength58
IndustryPackaged Foods
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,086,971
10 Day Avg. Volume115,576
30 Day Avg. Volume2,242,045
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.09
Price to Sales (P/S)0.29
P/FCF Ratio-1.27
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue0.76
Enterprise Value/Gross Profit3.65
Enterprise Value/Ebitda645.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bon Natural Life Business Overview & Revenue Model
Company Description
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The...
How the Company Makes Money
Bon Natural Life (BON) primarily makes money by selling its natural health and wellness products (e.g., dietary supplements and related consumer health goods) to customers through its distribution and sales channels. Revenue is generated from prod...
Bon Natural Life Financial Statement Overview
Summary
Income Statement
33
Negative
Balance Sheet
62
Positive
Cash Flow
21
Negative
| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 18.67M | 23.84M | 29.52M | 29.91M | 25.49M |
| Gross Profit | 3.88M | 7.11M | 8.84M | 9.42M | 7.11M |
| EBITDA | -57.83K | 2.30M | 6.98M | 8.33M | 6.13M |
| Net Income | -1.99M | 398.17K | 4.60M | 6.24M | 4.59M |
Balance Sheet | |||||
| Total Assets | 85.19M | 61.77M | 46.56M | 37.26M | 36.41M |
| Cash, Cash Equivalents and Short-Term Investments | 6.27M | 80.47K | 111.30K | 840.86K | 3.61M |
| Total Debt | 12.32M | 7.30M | 4.21M | 5.41M | 3.21M |
| Total Liabilities | 27.19M | 17.42M | 10.57M | 7.16M | 9.88M |
| Stockholders Equity | 57.55M | 43.91M | 35.48M | 29.56M | 26.01M |
Cash Flow | |||||
| Free Cash Flow | -4.23M | -7.73M | -713.82K | -4.92M | -700.78K |
| Operating Cash Flow | 141.12K | -7.72M | -651.91K | -187.12K | 4.05M |
| Investing Cash Flow | -10.00M | -15.73K | -1.19M | -3.06M | -7.44M |
| Financing Cash Flow | 15.45M | 8.76M | 1.16M | 2.26M | 5.35M |
Bon Natural Life Technical Analysis
Negative
1.70
Price Trends
1.54
Negative
1.64
Negative
1.64
Negative
Market Momentum
-0.07
Positive
33.72
Neutral
47.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BON, the sentiment is Negative. The current price of 1.7 is above the 20-day moving average (MA) of 1.41, above the 50-day MA of 1.54, and above the 200-day MA of 1.64, indicating a bearish trend. The MACD of -0.07 indicates Positive momentum. The RSI at 33.72 is Neutral, neither overbought nor oversold. The STOCH value of 47.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BON.
Bon Natural Life Risk Analysis
Bon Natural Life disclosed 48 risk factors in its most recent earnings report. Bon Natural Life reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Bon Natural Life Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
50 Neutral | $27.31M | -3.33 | -14.36% | ― | 17.73% | -34.71% | |
46 Neutral | $10.81M | -2.69 | -3.59% | ― | -15.44% | -94.04% | |
46 Neutral | $16.55M | -2.11 | -17.43% | ― | 18.19% | -35.22% | |
46 Neutral | $5.78M | -1.06 | -74.59% | ― | ― | ― | |
44 Neutral | $16.85M | -0.07 | -36.55% | ― | -49.19% | -394.71% |
* Basic Materials Sector Average
BON
Bon Natural Life
1.33
-0.23
-14.74%
PLAG
Planet Green Holdings
1.44
0.20
16.13%
NAII
Natural Alternatives International
2.68
-0.31
-10.37%
FAMI
Farmmi
1.22
-0.41
-25.15%
LSF
Laird Superfood
2.50
-2.28
-47.70%
HCWC
Healthy Choice Wellness Corp. Class A
0.25
-0.14
-34.87%
Bon Natural Life Corporate Events
Bon Natural Life Names New CTO After Sudden March Resignation
Mar 19, 2026
On March 12, 2026, Bon Natural Life’s Chief Technology Officer and Chief Scientist, Jianli Liu, resigned from all his positions with immediate effect, with the company stating there were no known disagreements related to its operations, poli...
Bon Natural Life Deepens AI-Driven Biomanufacturing Push With Chang’an Pilot Joint Lab
Feb 17, 2026
Bon Natural Life Limited, a Nasdaq-listed supplier of natural active ingredients for health and personal care products, operates globally with a portfolio spanning plant-based extracts, functional food ingredients and personal care actives. The co...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.